Huang C, Ren L, Kirkpatrick J, Wang Z
Duke University Medical Center, Durham, NC.
Med Phys. 2012 Jun;39(6Part20):3854. doi: 10.1118/1.4735734.
To investigate the treatment of multiple brain metastases using stereotactic radiosurgery with single-isocenter volumetric modulated arc therapy (VMAT) compared with conventional multi-isocenter dynamic conformal arc therapy (DCAT) and three-dimensional conformal radiation therapy (3D-CRT).
Seventeen patients with 2 to 5 brain metastatic lesions were studied. The number of patients with 5, 4, 3, and 2 lesions were 4, 5, 4, and 4, respectively. For patients treated with DCAT/3D-CRT plans, VMAT plans were retrospectively generated, and vice versa. Single-isocenter set up was employed in VMAT plans while the number of isocenters was proportional to the number of lesions in DCAT/3D-CRT plans. The DCAT/3D-CRT and VMAT plans were generated using iPlan® RT Dose Version 4.1.1 (BrainLAB, Germany) and Eclipse™ Version 8.6 (Varian, USA) treatment planning system, respectively. All plans were designed to be delivered on Novalis Tx™ system (Varian, USA and BrainLAB, Germany), in which the accelerator equipped with a high definition multileaf collimator (HDMLC).
Conformity index for VMAT plans were equivalent to or better than that for DCAT/3D-CRT plans. While VMAT and DCAT/3D-CRT plans were similar in target coverage, quality of coverage for VMAT plans was better. However, the volume receiving 5Gy was 46% larger for VMAT plans. In addition, the distance from individual lesion to the VMAT isocenter has no impact on VMAT plans. Compared with DCAT/3D-CRT plans, the mean monitor units (MU) decreased by 42% and the estimated treatment time decreased by 49% for VMAT plans.
This work suggests that single-isocenter VMAT is promising for stereotactic radiosurgery in the treatment of multiple brain metastases. Single-isocenter VMAT is able to achieve comparable conformity, target coverage and quality of coverage with significantly superior delivery efficiency.
比较采用单等中心容积调强弧形放疗(VMAT)的立体定向放射外科治疗与传统多等中心动态适形弧形放疗(DCAT)及三维适形放疗(3D-CRT)对多发脑转移瘤的治疗效果。
对17例有2至5个脑转移瘤病灶的患者进行研究。病灶数为5个、4个、3个和2个的患者分别有4例、5例、4例和4例。对于接受DCAT/3D-CRT计划治疗的患者,回顾性生成VMAT计划,反之亦然。VMAT计划采用单等中心设置,而DCAT/3D-CRT计划中的等中心数量与病灶数量成正比。DCAT/3D-CRT和VMAT计划分别使用iPlan® RT Dose Version 4.1.1(德国BrainLAB公司)和Eclipse™ Version 8.6(美国瓦里安公司)治疗计划系统生成。所有计划均设计在Novalis Tx™系统(美国瓦里安公司和德国BrainLAB公司)上实施,该系统的加速器配备了高清多叶准直器(HDMLC)。
VMAT计划的适形指数等同于或优于DCAT/3D-CRT计划。虽然VMAT和DCAT/3D-CRT计划在靶区覆盖方面相似,但VMAT计划的覆盖质量更好。然而,VMAT计划中接受5Gy剂量的体积要大46%。此外,单个病灶到VMAT等中心的距离对VMAT计划没有影响。与DCAT/3D-CRT计划相比,VMAT计划的平均监测单位(MU)减少了42%,估计治疗时间减少了49%。
本研究表明,单等中心VMAT在多发脑转移瘤的立体定向放射外科治疗中具有前景。单等中心VMAT能够实现相当的适形性、靶区覆盖和覆盖质量,且具有显著更高的实施效率。